Washington, D.C., (December 4, 2018) —MedStar Heart in partnership with CardioCell has been approved to conduct an investigational new drug clinical trial, called STEMVAD at MedStar Heart & Vascular Institute. The goal of this study is to determine whether stem cell therapy improves myocardial function in patients with severe heart failure. “Innovative therapies to improve heart function and outcomes of patients with advanced heart failure are sorely needed,” said Selma Mohammed, MD, PhD. Read more.
Recent Posts
- MedStar Investigators Report on Myocardial Injury from COVID-19
MedStar Health researchers published a report highlighting two cases of COVID-19 infection with myoc... - Collaborative Research from MedStar Investigators Evaluates Racial Variations in Takotsubo Cardiomyopathy Outcomes
A collaborative team of researchers from across MedStar Health and partners published their work to ... - June Peer-Reviewed Publications from MedStar Health
Congratulations to all MedStar researchers who had articles published in June 2020. The selected ...
Contact
Eva Hochberger
Communications & Planning Manager
Phone: 301-560-2917
[email protected]